M. K. Proteins Ltd (MKPL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by M. K. Proteins Ltd on NSE and BSE, with an AI summary of each filing.
M K PROTEINS LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 13 Nov 2026, 5:30 am
M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
Intimation · 13 Nov 2026, 5:30 am
M K Proteins Schedules Board Meeting to Approve Q2 and H1 Financial Results M K Proteins Limited has scheduled its Board of Directors meeting on 13th Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Pursuant to SEBI Prohibition of Insider Trading Regulations, the trading window for dealing in the company's equity shares will remain closed and will reopen 48 hours after the declaration of the financial results.
M K PROTEINS LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 13 Nov 2026, 5:30 am
Meeting of the Board of Directors of the Company will be held on Friday, 13th November, 2026, inter alia, to consider and approve the the Un-audited Financial Results of the Company for the quarter and half year ended 30th September, 2026;
Intimation · 13 Nov 2026, 5:30 am
We hereby inform you that at the 14th Annual General Meeting of the Company duly convened on September 30th, 2026, the shareholders of the company approved the appointment of Ms. Aritika ....
Change in Management · 01 Oct 2026, 10:39 pm
Pursuant to Regulation 44(3) of the SEBI (LODR), 2015, the details of the e-voting results of the 14th Annual General Meeting of the Company held on September 30th, 2026, is enclosed herewith ....
Annual General Meeting · 01 Oct 2026, 10:27 pm
Pursuant to the Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that an Annual General Meeting of the Members of the Company was held on Wednesday, 30th September, ....
Annual General Meeting · 30 Sept 2026, 6:02 pm
This is to inform you that, pursuant to the Regulation 36(1)(b) of the SEBI (LODR) Regulations, a letter is being sent by the Company to those Members whose email addresses are not registered ....
Annual Report · 04 Sept 2026, 9:45 pm
The 14th Annual General Meeting of the members of M K Proteins Limited is scheduled to be held on Wednesday, 30th September 2026 at 11:00 A.M. through VC/OAVM in accordance with the circulars ....
Others · 04 Sept 2026, 9:33 pm
Please find enclosed the Notice convening the 14th AGM of the shareholders of the Company and the Annual Report for the Financial Year ended 31st March, 2026. The same is being circulated ....
Others (Uncategorized) · 04 Sept 2026, 9:29 pm
Pursuant to Regulation 30 of SEBI (LODR) 2015, please find enclosed the Notice convening the 14th AGM of the shareholders of the Company that is scheduled to be held on Wednesday, the 30th ....
Annual General Meeting · 04 Sept 2026, 9:16 pm
This is to inform that the Board of Directors of the Company at their Meeting held on 2nd September 2026 discussed and approved: 1. Notice and Directors Report: The Board approved the ....
Others (Uncategorized) · 02 Sept 2026, 9:18 pm
M K Proteins Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026.
Outcome · 02 Sept 2026, 9:12 pm
M. K. Proteins Board Approves 14th AGM Schedule and Book Closure Dates M. K. Proteins Limited's board approved the schedule for its 14th Annual General Meeting (AGM) and the accompanying Directors Report during its meeting on 2nd Sep'26. The virtual AGM is scheduled for 30th Sep'26 at 11:00 A.M. For the purpose of holding this AGM, the company announced a book closure period, with the Register of Members and Share Transfer Books remaining closed from 24th Sep'26 to 30th Sep'26, inclusive.
This is to inform that the Board of Directors of the Company at their Meeting held on 22nd August 2026 approved: (i) the appointment of Independent Director: Ms. Aritika Garg (DIN: 11895058) ....
Change in Management · 22 Aug 2026, 9:20 pm
This is to inform that the Board of Directors of the Company at their Meeting held on 22nd August 2026 approved: i) the appointment of Independent Director i.e. Ms. Aritika Garg (DIN: ....
Others (Uncategorized) · 22 Aug 2026, 9:13 pm
We hereby inform that the Board of Directors of the Company at its meeting held today i.e. on 13th August, 2026, approved the Un-Audited Financial Results of the Company for the quarter ....
Financial Result · 13 Aug 2026, 10:24 pm
MK Proteins Q1 FY27 PAT Plummets 61% YoY; Board Notes Director Resignation M. K. Proteins reported weak Q1 FY27 results with Profit After Tax (PAT) at ₹138.24 lacs, a sharp 60.6% decline YoY and a 21.6% rise QoQ. Revenue from operations was flat YoY at ₹11,516.12 lacs but fell 21.1% sequentially. Expenses remained largely flat YoY, contributing to margin compression. Profit before tax stood at ₹184.74 lacs, down 60.7% YoY. Basic EPS for the quarter was ₹0.04 versus ₹0.09 in Q1 FY26. The board also noted the resignation of Independent Director Ms. Laxmi Mandal effective 12th Aug'26.
We hereby inform that the Board of Directors of the Company at its meeting held today i.e. on 13th August, 2026: 1. approved the Un-Audited Financial Results of the Company for the quarter ....
Outcome · 13 Aug 2026, 10:13 pm
M. K. Proteins Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 11,516 (+0.2% YoY | -21.1% QoQ) ■ EBITDA: 251 (-54.4% YoY | +0.7% QoQ) ■ EBITDA Margin (%): 2.2 (-261 bps YoY | +47 bps QoQ) ■ PAT: 138 (-60.7% YoY | +21.4% QoQ) ■ EPS (INR): 0.04 (-55.6% YoY | +33.3% QoQ)
In terms of Regulation 30 of the SEBI (LODR) Regulations, 2015 read with Para A of Part A of Schedule III to the said Regulations, we wish to inform you that Ms. Laxmi Mandal (DIN: 05287716) ....
Change in Management · 13 Aug 2026, 5:30 pm
M K Proteins: Independent Director Laxmi Mandal Resigns Ms. Laxmi Mandal (DIN: 05287716) has resigned from her position as Independent Director of M K Proteins, effective 12th Aug'26. The company filing cites "other business obligations" as the reason for her departure. The company has confirmed there are no other material reasons for the resignation. Ms. Mandal does not hold directorships in any other listed entities. This event is a standard board-level change with no immediate disclosed impact on company operations or strategy.
M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the following businesses: 1. ....
Intimation · 13 Aug 2026, 5:30 am
MK Proteins Board Meeting on 13th Aug'26 to Approve Q1 FY27 Results M. K. Proteins Limited scheduled a Board of Directors meeting on 13th Aug'26 to consider and approve its un-audited financial results for the quarter ended 30th Jun'26. In accordance with SEBI regulations, the trading window for the company's equity shares will re-open 48 hours after the declaration of these results. This meeting is a key event for the release of the company's Q1 FY27 performance data.
We hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Friday, May 29, 2026, inter alia, considered and approved the following matters: 1. Re-appointment ....
Change in Auditor · 29 May 2026, 11:10 pm
MK Proteins Q4 & FY26 Results: PAT Declines, Revenue Grows MK Proteins reported a Q4 FY26 net profit of ₹113.83 lakhs, a decline from ₹279.61 lakhs YoY. Revenue from operations grew to ₹14,594.06 lakhs from ₹13,720.41 lakhs YoY. For the full year FY26, net profit was ₹682.90 lakhs, down from ₹839.74 lakhs in FY25, while revenue rose to ₹38,287.52 lakhs from ₹26,770.60 lakhs. The board approved the audited financials, re-appointed cost and internal auditors for FY27, and confirmed an unmodified audit opinion. Basic EPS for FY26 stood at ₹0.18.
We hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Friday, May 29, 2026, inter alia, considered and approved the following matters: 1. Audited ....
Financial Result · 29 May 2026, 10:47 pm
M K Proteins Q4FY26 PAT Declines on Lower Revenue M. K. Proteins reported a Q4FY26 standalone Profit After Tax (PAT) of ₹113.83 lakhs, a 59% YoY and 20% QoQ decline. Revenue from operations for the quarter stood at ₹14,594.06 lakhs, up 6.4% YoY but down from the previous quarter's strong performance. For the full year FY26, PAT was ₹682.90 lakhs, a 19% YoY decrease, while revenue grew 43% YoY to ₹38,287.52 lakhs. The Board approved the audited financials and confirmed an unmodified audit opinion for the year ended 31st Mar'26.
We hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Friday, May 29, 2026, inter alia, considered and approved the following matters: 1. Audited ....
Outcome · 29 May 2026, 10:18 pm
M. K. Proteins Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakh) ■ Revenue: 14,594 (+6.4% YoY | +63.0% QoQ) ■ EBITDA: 250 (-46.4% YoY | +5.6% QoQ) ■ EBITDA Margin (%): 1.7 (-168 bps YoY | -93 bps QoQ) ■ PAT: 114 (-59.3% YoY | -20.4% QoQ) ■ EPS (INR): 0.03 (-57.1% YoY | -25.0% QoQ)
M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial Results for ....
Intimation · 29 May 2026, 5:30 am
M. K. Proteins Board Meeting on May 29 to Approve Q4 & FY26 Results M. K. Proteins has scheduled a Board of Directors meeting for 29th May'26 to consider and approve audited financial results for the quarter and year ended 31st Mar'26. The agenda also includes the re-appointment of the company's cost and internal auditors for FY27. The trading window will reopen 48 hours after the declaration of the financial results.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 30 Apr 2026, 9:54 pm
M K Proteins Confirms Non-Large Corporate Status M K Proteins Limited (MKPL) formally disclosed on 30 Apr'26 that it does not qualify as a 'Large Corporate' under SEBI's framework as of 31 Mar'26. Consequently, the mandatory borrowing requirements for large entities are not applicable to the company. The filing confirmed outstanding borrowings of Rs. 36.19 crore and noted its highest credit rating from CRISIL is 'A' for both long-term and short-term bank facilities. This status exempts the company from potential penalties related to debt market borrowing shortfalls.
Un-Audited Financial Results along with the Limited Review Report (LRR) of the Company for the quarter and nine months ended 31st December, 2025 are enclosed.
Financial Result · 13 Feb 2026, 9:52 pm
MK Proteins Q3 FY26 Net Profit Rises 4.0% YoY MK Proteins reported a consolidated net profit of ₹143.08 lacs for Q3 FY26, a 4.0% YoY increase but a 92.2% QoQ jump from ₹74.67 lacs. Revenue from operations grew 128.8% YoY and 176.2% QoQ to ₹8,955.83 lacs. Profit before tax (PBT) stood at ₹196.63 lacs, up 5.8% YoY and 96.7% QoQ. For the nine months ending 31st Dec’25, net profit increased 1.6% YoY to ₹569.07 lacs on revenue of ₹23,693.46 lacs. Basic EPS for the quarter was ₹0.04, flat YoY.